Development and Validation of the San Diego Early Test Score to Predict Acute and Early HIV Infection Risk in Men Who Have Sex with Men

Clinical Infectious Diseases

Volumn 61, Issue 3, 2015, Pages 468-475

  Hoenigl, Martin ^a,b,c   Weibel, Nadir ^d   Mehta, Sanjay R ^a,e   Anderson, Christy M ^a   Jenks, Jeffrey ^a   Green, Nella ^a   Gianella, Sara ^a   Smith, Davey M ^a,e   Little, Susan J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Section of Infectious Diseases and Tropical Medicine   (United States)

^c MEDICAL UNIVERSITY OF GRAZ   (Austria)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

Author keywords

acute and early HIV; MSM; risk behavior; risk score

Indexed keywords

ADULT; ANAL INTERCOURSE; AREA UNDER THE CURVE; ARTICLE; ASSESSMENT OF HUMANS; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; HIV TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MEN WHO HAVE SEX WITH MEN; PREDICTION; PREDICTIVE VALUE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RECEPTIVE INTERCOURSE; RETROSPECTIVE STUDY; SAN DIEGO EARLY TEST; SCREENING; SENSITIVITY AND SPECIFICITY; VALIDATION STUDY; HIV INFECTIONS; MALE HOMOSEXUALITY; RANDOMIZATION; REPRODUCIBILITY; RISK ASSESSMENT; STATISTICS AND NUMERICAL DATA; TRANSMISSION;

ADULT; HIV INFECTIONS; HOMOSEXUALITY, MALE; HUMANS; MALE; RANDOM ALLOCATION; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; RISK ASSESSMENT;

EID: 84938575381     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/civ335     Document Type: Article

References (39)

1. Fisher HH, Habarta N, Hardnett F, et al. Characteristics of first-time and repeat HIV tests among men who have sex with men who test at CDC-supported sites, 2007. AIDS Educ Prev 2011; 23(3 suppl):17-29.
2. Baral S, Sifakis F, Cleghorn F, Beyrer C. Elevated risk for HIV infection among men who have sex with men in low-and middle-income countries 2000-2006: a systematic review. PLoS Med 2007; 4:e339.
3. Koblin BA, Husnik MJ, Colfax G, et al. Risk factors for HIV infection among men who have sex with men. AIDS 2006; 20:731-9.
4. MacKellar DA, Valleroy LA, Secura GM, et al. Repeat HIV testing, risk behaviors, and HIV seroconversion among young men who have sex with men: a call to monitor and improve the practice of prevention. J Acquir Immune Defic Syndr 2002; 29:76-85.
5. Menza TW, Hughes JP, Celum CL, Golden MR. Prediction of HIV acquisition among men who have sex with men. Sex Transm Dis 2009; 36:547-55.
6. Marrazzo JM, del Rio C, Holtgrave DR, et al. HIV prevention in clinical care settings: 2014 recommendations of the International Antiviral Society-USA panel. JAMA 2014; 312:390-409.
7. Wahome E, Fegan G, Okuku HS, et al. Evaluation of an empiric risk screening score to identify acute and early HIV-1 infection among MSM in coastal Kenya. AIDS 2013; 27:2163-6.
8. Powers KA, Miller WC, Pilcher CD, et al. Improved detection of acute HIV-1 infection in sub-Saharan Africa: development of a risk score algorithm. AIDS 2007; 21:2237-42.
9. Haukoos JS, Lyons MS, Lindsell CJ, et al. Derivation and validation of the Denver human immunodeficiency virus (HIV) risk score for targeted HIV screening. Am J Epidemiol 2012; 175:838-46.
10. Hsieh YH, Haukoos JS, Rothman RE. Validation of an abbreviated version of the Denver HIV risk score for prediction of HIV infection in an urban ED. Am J Emerg Med 2014; 32:775-9.
11. Smith DK, Pals SL, Herbst JH, Shinde S, Carey JW. Development of a clinical screening index predictive of incident HIV infection among men who have sex with men in the United States. J Acquir Immune Defic Syndr 2012; 60:421-7.
12. Koblin B, Chesney M, Coates T; EXPLORE Study Team. Effects of a behavioural intervention to reduce acquisition of HIV infection among men who have sex with men: the EXPLORE randomised controlled study. Lancet 2004; 364:41-50.
13. US Public Health Service. Preexposure prophylaxis for the prevention of HIV infection in the United States-2014. Clinical providers' supplement, 2014. Available at: http://www.cdc.gov/hiv/pdf/guidelines/ PrEPProviderSupplement2014.pdf. Accessed 8 April 2015.
14. Morris SR, Little SJ, Cunningham T, Garfein RS, Richman DD, Smith DM. Evaluation of an HIV nucleic acid testing program with automated internet and voicemail systems to deliver results. Ann Intern Med 2010; 152:778-85.
15. Le T, Wright EJ, Smith DM, et al. Enhanced CD4+ T-cell recovery with earlier HIV-1 antiretroviral therapy. N Engl J Med 2013; 368:218-30.
16. Hare CB, Pappalardo BL, Busch MP, et al. Seroreversion in subjects receiving antiretroviral therapy during acute/early HIV infection. Clin Infect Dis 2006; 42:700-8.
17. Hurt CB, McCoy SI, Kuruc J, et al. Transmitted antiretroviral drug resistance among acute and recent HIV infections in North Carolina from 1998 to 2007. Antivir Ther 2009; 14:673-8.
18. Drabkin AS, Sikkema KJ, Wilson PA, et al. Risk patterns preceding diagnosis among newly HIV-diagnosed men who have sex with men in New York City. AIDS Patient Care STDS 2013; 27:333-41.
19. Buchbinder SP, Vittinghoff E, Heagerty PJ, et al. Sexual risk, nitrite inhalant use, and lack of circumcision associated with HIV seroconversion in men who have sex with men in the United States. J Acquir Immune Defic Syndr 2005; 39:82-9.
20. Zetola NM, Bernstein KT,Wong E, Louie B, Klausner JD. Exploring the relationship between sexually transmitted diseases and HIV acquisition by using different study designs. J Acquir Immune Defic Syndr 2009; 50:546-51.
21. Ferrer L, Furegato M, Foschia JP, et al. Undiagnosed HIV infection in a population of MSM from six European cities: results from the Sialon Project. Eur J Public Health 2014; doi:10.1093/eurpub/cku139.
22. Ostrow DG, Plankey MW, Cox C, et al. Specific sex drug combinations contribute to the majority of recent HIV seroconversions among MSM in the MACS. J Acquir Immune Defic Syndr 2009; 51:349-55.
23. Schwarcz S, Scheer S, McFarland W, et al. Prevalence of HIV infection and predictors of high-transmission sexual risk behaviors among men who have sex with men. Am J Public Health 2007; 97:1067-75.
24. PlankeyMW, Ostrow DG, Stall R, et al. The relationship between methamphetamine and popper use and risk of HIV seroconversion in the Multicenter AIDS Cohort Study. J Acquir Immune Defic Syndr 2007; 45:85-92.
25. Chen YH, McFarland W, Raymond HF. Risk behaviors for HIV in sexual partnerships of San Francisco injection drug users. AIDS Care 2014; 26:554-8.
26. Salzer HJ, Hoenigl M, Kessler HH, et al. Lack of risk-awareness and reporting behavior towards HIV infection through needlestick injury among European medical students. Int J Hyg Environ Health 2011; 214:407-10.
27. Thiede H, Jenkins RA, Carey JW, et al. Determinants of recent HIV infection among Seattle-area men who have sex with men. Am J Public Health 2009; 99(suppl 1):S157-64.
28. Drumright LN, Gorbach PM, Little SJ, Strathdee SA. Associations between substance use, erectile dysfunction medication and recent HIV infection among men who have sex with men. AIDS Behav 2009; 13:328-36.
29. Johnston LD, O'Malley PM, Bachman JG, Schulenberg JE. Monitoring the future national results on drug use: 2012 overview, key findings on adolescent drug use. Ann Arbor: Institute for Social Research, University of Michigan, 2013.
30. Freeman P, Walker BC, Harris DR, et al. Methamphetamine use and risk for HIV among young men who have sex with men in 8 US cities. Arch Pediatr Adolesc Med 2011; 165:736-40.
31. Hanley JA, McNeil BJ. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 1983; 148:839-43.
32. Little SJ, Kosakovsky Pond SL, Anderson CM, et al. Using HIV networks to inform real time prevention interventions. PLoS One 2014; 9:e98443.
33. Gifford RJ, Liu TF, Rhee SY, et al. The calibrated population resistance tool: standardized genotypic estimation of transmitted HIV-1 drug resistance. Bioinformatics 2009; 25:1197-8.
34. Bennett DE, Camacho RJ, Otelea D, et al. Drug resistance mutations for surveillance of transmitted HIV-1 drug-resistance: 2009 update. PLoS One 2009; 4:e4724.
35. Shoptaw S, Reback CJ. Associations between methamphetamine use and HIV among men who have sex with men: a model for guiding public policy. J Urban Health 2006; 83:1151-7.
36. Marsolek MR, White NC, Litovitz TL. Inhalant abuse: Monitoring trends by using poison control data, 1993-2008. Pediatrics 2010; 125:906-13.
37. Raymond HF, Chen YH, Ick T, et al. A new trend in the HIV epidemic among men who have sex with men, San Francisco, 2004-2011. J Acquir Immune Defic Syndr 2013; 62:584-9.
38. Centers for Disease Control and Prevention (CDC). HIV testing and risk behaviors among gay, bisexual, and other men who have sex with men-United States. MMWR Morb Mortal Wkly Rep 2013; 62:958-62.
39. Touloumi G, Pantazis N, Pillay D, et al. Impact ofHIV-1 subtype on CD4 count at HIV seroconversion, rate of decline, and viral load set point in European seroconverter cohorts. Clin Infect Dis 2013; 56:888-97.